SABBY MANAGEMENT, LLC - ONCOGENEX PHARMACEUTICALS IN ownership

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 65 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 9.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2014$1,058,000
-49.7%
461,957
-41.3%
0.03%
-59.3%
Q3 2014$2,102,000
-38.9%
787,088
-14.7%
0.08%
-45.3%
Q2 2014$3,441,000
+17.0%
922,562
+161.5%
0.15%
-21.3%
Q4 2013$2,942,000
-22.7%
352,800
-14.1%
0.19%
-23.9%
Q3 2013$3,806,000
-2.1%
410,577
+3.5%
0.25%
-5.0%
Q2 2013$3,888,000396,7300.26%
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q2 2013
NameSharesValueWeighting ↓
Steamboat Capital Partners, LLC 817,521$414,0000.37%
Abingworth LLP 396,104$195,0000.19%
BOOTHBAY FUND MANAGEMENT, LLC 60,638$31,0000.01%
EAGLE GLOBAL ADVISORS LLC 128,520$65,0000.00%
PANAGORA ASSET MANAGEMENT INC 949,438$481,0000.00%
Renaissance Technologies 908,100$460,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$23,0000.00%
DEUTSCHE BANK AG\ 5$00.00%
CITIGROUP INC 10,376$5,0000.00%
GOLDMAN SACHS GROUP INC 20,037$10,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders